Participants 308 376 5
patients with type 2 diabetes (T2D) and inadequate glycaemic control
Participants 475 536 4
metformin-tolerant patients with T2D on metformin monotherapy
Participants 1213 1225 5
al of 286 pa
Participants 2012 2111 4
ONCLUSIONS In metformin-tolerant patients with T2D (inadequately controlled on sub-maximal metformi
